Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Recursion Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10958
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformation, cornelia de lange syndrome, spinal muscular atrophy, hereditary hemorrhagic telangiectasia type 2, kabuki syndrome, treacher collins syndrome, emery-dreifuss muscular dystrophy, walker-warburg syndrome, and others. Recursion Pharmaceuticals utilizes the genetic manipulation to model many diseases in multiple human cells. The company works in partnership with other pharmaceutical companies to develops new drugs. Recursion Pharmaceuticals is headquartered in Salt Lake City, Utah, the US.

Recursion Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Recursion Pharma Raises USD60 Million in Series B Financing 11
Recursion Pharma Raises Additional USD2.2 Million in Series A Financing 13
Recursion Pharma Raises USD13 Million in Series A Financing 14
Recursion Pharma Raises USD32 Million Venture Financing 15
Recursion Pharma Raises USD4 Million Venture Financing 16
Recursion Pharma Raise USD2.6 Million in Seed Financing 17
Recursion Pharmaceuticals Raises USD0.83 Million in Venture Funding 18
Recursion Pharma Raises USD0.08 Million in Venture Financing 19
Partnerships 20
Recursion Pharma Enters into Agreement with Takeda Pharma 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Recursion Pharmaceuticals Inc – Key Competitors 22
Recursion Pharmaceuticals Inc – Key Employees 23
Recursion Pharmaceuticals Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Jul 10, 2018: Recursion Appoints Tina M. Larson As Chief Operating Officer 25
May 01, 2018: Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer 26
Oct 17, 2017: Dr. Martin Brenner Joins Recursion to Accelerate an Ambitious Plan to Industrialize Drug Discovery 27
Jun 28, 2017: Dr. Chand Sishta to lead regulatory affairs for Recursion Pharmaceuticals 28
Government and Public Interest 29
May 07, 2018: Recursion Pharmaceuticals Receives Grant to Leverage AI-Enabled Discovery Platform in Infectious Disease 29
Clinical Trials 30
Jul 10, 2018: Recursion Receives FDA Clearance of Investigational New Drug Application to Initiate First Clinical Trial of REC-994 in Cerebral Cavernous Malformation 30
Other Significant Developments 31
Nov 07, 2017: Splunk Machine Learning Helps Recursion Pharmaceuticals Treat Genetic Diseases 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recursion Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recursion Pharma Raises USD60 Million in Series B Financing 11
Recursion Pharma Raises Additional USD2.2 Million in Series A Financing 13
Recursion Pharma Raises USD13 Million in Series A Financing 14
Recursion Pharma Raises USD32 Million Venture Financing 15
Recursion Pharma Raises USD4 Million Venture Financing 16
Recursion Pharma Raise USD2.6 Million in Seed Financing 17
Recursion Pharmaceuticals Raises USD0.83 Million in Venture Funding 18
Recursion Pharma Raises USD0.08 Million in Venture Financing 19
Recursion Pharma Enters into Agreement with Takeda Pharma 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Recursion Pharmaceuticals Inc, Key Competitors 22
Recursion Pharmaceuticals Inc, Key Employees 23

List of Figures
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recursion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務情報
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Coloplast A/S:戦略・SWOT・企業財務分析
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Imbed Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Imbed Biosciences Inc (Imbed) is a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biof …
  • Enbridge Energy Partners LP (EEP)-石油・ガス分野:企業M&A・提携分析
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TeleTech Holdings, Inc. (TTEC):企業の財務・戦略的SWOT分析
    TeleTech Holdings, Inc. (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China National Offshore Oil Corp:企業の戦略的SWOT分析
    China National Offshore Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • British Columbia Ferry Services Inc.:企業の戦略的SWOT分析
    British Columbia Ferry Services Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Attana AB-製薬・医療分野:企業M&A・提携分析
    Summary Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, atta …
  • Skechers USA Inc (SKX):企業の財務・戦略的SWOT分析
    Skechers USA Inc (SKX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AIB Group Plc:企業の戦略・SWOT・財務情報
    AIB Group Plc - Strategy, SWOT and Corporate Finance Report Summary AIB Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cancer Genetics Inc (CGIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Aldevron LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aldevron LLC (Aldevron) is a custom manufacturing and development service provider. The company manufactures plasmid deoxyribonucleic acid for research, preclinical and clinical applications. It offers nucleic acid, protein, and antibody services. Aldevron's protein production services inclu …
  • Inscape Corporation:企業の戦略・SWOT・財務情報
    Inscape Corporation - Strategy, SWOT and Corporate Finance Report Summary Inscape Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hon Hai Precision Industry Co Ltd (2317):企業の財務・戦略的SWOT分析
    Hon Hai Precision Industry Co Ltd (2317) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆